遗传职责。
GENETIC DUTIES.
作者信息
Roberts Jessica L, Foulkes Alexandra L
机构信息
University of Houston Law Center.
United States District Court for the Western District of Oklahoma.
出版信息
William Mary Law Rev. 2020 Oct;62(1):143-211.
Abstract
Most of our genetic information does not change, yet the results of our genetic tests might. Labs reclassify genetic variants in response to advances in genetic science. As a result, a person who took a test in 2010 could take the same test with the same lab in 2020 and get a different result. However, no legal duty requires labs or physicians to inform patients when a lab reclassifies a variant, even if the reclassification communicates clinically actionable information. This Article considers the need for such duties and their potential challenges. In so doing, it offers much-needed guidance to physicians and labs, who may face liability, and to courts, which will hear these cases.
摘要
我们的大部分基因信息不会改变，但基因检测的结果可能会变。实验室会根据基因科学的进展对基因变异进行重新分类。因此，一个在2010年做过检测的人，2020年在同一家实验室做同样的检测，可能会得到不同的结果。然而，即使重新分类传达了具有临床可操作性的信息，法律也没有规定实验室或医生有义务在实验室对变异进行重新分类时告知患者。本文探讨了此类义务的必要性及其潜在挑战。在此过程中，它为可能面临责任的医生和实验室以及将审理这些案件的法院提供了急需的指导。
相似文献
1
GENETIC DUTIES.
William Mary Law Rev. 2020 Oct;62(1):143-211.
2
Independent medical examinations: an expanding source of physician liability.
Ann Intern Med. 2005 Jun 21;142(12 Pt 1):974-8. doi: 10.7326/0003-4819-142-12_part_1-200506210-00007.
3
From the History of the Croatian Dermatovenereological Society - The Croatian Medical Association and an Overview of Important Information Regarding the Journal Acta Dermatovenerologica Croatica.
Acta Dermatovenerol Croat. 2018 Dec;26(4):344-348.
4
Exploring the potential duty of care in clinical genomics under UK law.
Med Law Int. 2017 Sep;17(3):158-182. doi: 10.1177/0968533217721966. Epub 2017 Aug 14.
5
Finding Fault? Exploring Legal Duties to Return Incidental Findings in Genomic Research.
Georgetown Law J. 2014;102:795-843.
6
[The origin of informed consent].
Acta Otorhinolaryngol Ital. 2005 Oct;25(5):312-27.
7
Legal Challenges in Precision Medicine: What Duties Arising From Genetic and Genomic Testing Does a Physician Owe to Patients?
Front Med (Lausanne). 2021 Jul 26;8:663014. doi: 10.3389/fmed.2021.663014. eCollection 2021.
8
To warn and to control: two distinct legal obligations or variations of a single duty to protect?
Behav Sci Law. 2001;19(3):355-73. doi: 10.1002/bsl.451.
9
Avoiding Liability and Other Legal Land Mines in the Evolving Genomics Landscape.
Annu Rev Genomics Hum Genet. 2023 Aug 25;24:333-346. doi: 10.1146/annurev-genom-100722-021725. Epub 2023 Jan 11.
10
A Tarasoff for Europe? A European Human Rights perspective on the duty to protect.
Int J Law Psychiatry. 2007 May-Jun;30(3):255-67. doi: 10.1016/j.ijlp.2007.01.001. Epub 2007 Apr 24.
引用本文的文献
1
UNLIMITED MEDICAL LIABILITY?
Emory Law J Online. 2022;72.
2
Cases in Precision Medicine: Is There an Obligation to Return Reinterpreted Genetic Results to Former Patients?
Ann Intern Med. 2023 Apr;176(4):563-567. doi: 10.7326/M22-3682. Epub 2023 Mar 28.
3
Practical considerations for reinterpretation of individual genetic variants.
Genet Med. 2023 May;25(5):100801. doi: 10.1016/j.gim.2023.100801. Epub 2023 Feb 4.
4
How should we address the inevitable harms from non-negligent variant reclassification in predictive genetic testing?
J Genet Couns. 2023 Feb;32(1):18-30. doi: 10.1002/jgc4.1638. Epub 2022 Oct 19.
5
Challenges of variant reinterpretation: Opinions of stakeholders and need for guidelines.
Genet Med. 2022 Sep;24(9):1878-1887. doi: 10.1016/j.gim.2022.06.002. Epub 2022 Jun 29.
6
An Ethics Checklist for Digital Health Research in Psychiatry: Viewpoint.
J Med Internet Res. 2022 Feb 9;24(2):e31146. doi: 10.2196/31146.
7
Of Screening, Stratification, and Scores.
J Pers Med. 2021 Jul 28;11(8):736. doi: 10.3390/jpm11080736.
本文引用的文献
1
Can Clinical Genetics Laboratories be Sued for Medical Malpractice?
Ann Health Law Life Sci. 2020 Winter;29(1):153-172.
2
Is there a duty to reinterpret genetic data? The ethical dimensions.
Genet Med. 2020 Mar;22(3):633-639. doi: 10.1038/s41436-019-0679-7. Epub 2019 Oct 15.
3
The Responsibility to Recontact Research Participants after Reinterpretation of Genetic and Genomic Research Results.
Am J Hum Genet. 2019 Apr 4;104(4):578-595. doi: 10.1016/j.ajhg.2019.02.025.
4
Experts reflecting on the duty to recontact patients and research participants; why professionals should take the lead in developing guidelines.
Eur J Med Genet. 2020 Feb;63(2):103642. doi: 10.1016/j.ejmg.2019.03.006. Epub 2019 Mar 20.
5
The effects of genomic germline variant reclassification on clinical cancer care.
Oncotarget. 2019 Jan 11;10(4):417-423. doi: 10.18632/oncotarget.26501.
6
Patient re-contact after revision of genomic test results: points to consider-a statement of the American College of Medical Genetics and Genomics (ACMG).
Genet Med. 2019 Apr;21(4):769-771. doi: 10.1038/s41436-018-0391-z. Epub 2018 Dec 22.
7
Recontacting patients in clinical genetics services: recommendations of the European Society of Human Genetics.
Eur J Hum Genet. 2019 Feb;27(2):169-182. doi: 10.1038/s41431-018-0285-1. Epub 2018 Oct 11.
8
Prevalence of Variant Reclassification Following Hereditary Cancer Genetic Testing.
JAMA. 2018 Sep 25;320(12):1266-1274. doi: 10.1001/jama.2018.13152.
9
Experiences of patients seeking to participate in variant of uncertain significance reclassification research.
J Community Genet. 2019 Apr;10(2):189-196. doi: 10.1007/s12687-018-0375-3. Epub 2018 Jul 19.
10
The impact of variant classification on the clinical management of hereditary cancer syndromes.
Genet Med. 2019 Feb;21(2):426-430. doi: 10.1038/s41436-018-0063-z. Epub 2018 Jun 6.
Zotero 插件